If you would like to present, start by submitting a proposal. You will need the following: presentation type, short/long descriptions, keywords, focus, themes, and biographical information.
Submit your proposal here.
After we receive your presentation proposal, it moves to the evaluation step. We welcome the submission of proposals at anytime of the year.
All proposals will be reviewed between 24- 48 hr of submission by the Organizing Committee. See proposal deadlines below.
Once your proposal is accepted, you must register before our Program Development team can schedule your presentation.
Full continuum of drug discovery and development, including genomics and proteomics reporting on research, applications, technologies, and strategies to accelerate the pace and productivity of drug research and development. Pharmacotherapy, Clinical research, Translational medicine, translational and preclinical models, Case studies across therapeutic and disease areas
Pharmacovigilance in Drug Regulation, Clinical Trials, Premarketing clinical safety, Postmarketing drug safety, Risk management strategies, Signal detection and data mining, Detection of drug interactions, International harmonization of drug regulatory requirements, Risk and crisis management, Herbal and Traditional Medicines, Vaccines and biological medicines
Recent therapeutic application and development approaches of formulation systems to improve the drug delivery potential. Drug Delivery Carrier, Administration routes, Future Opportunities and Challenges, Biomaterials in Drug Delivery, Drug Therapy
Nanoparticle synthesis, Nanocarriers, Applications of Pharmaceutical Nanotools, Future prospects of Pharmaceutical Nanotechnology, Nanomedicine and Drug Delivery, Toxicological assessment of nanomaterials as drugs. Characterization, clinical testing and biological evaluation of nanomaterials.
International Regulatory affairs, Quality assurance, Biosimilars, Biologic products, Liscencing and approvals, International Guidelines Impacting Regulatory Affairs, Clinical Trial, Regulatory and post-marketing issues.
Clinical Pharmacology including cardiac pharmacology and cardiovascular disease, pulmonary disease, neurodegenerative disorders, pharmacological oncology, Parkinson’s disease, circadian rhythm disorders, Molecular and Cellular Pharmacology including drug-receptor interactions, drug-enzyme interactions, pharmacology of antibiotics and immune responses, regulation of gene expression, Pharmacogenetics, Safety Pharmacology, Toxicology, Pharmacognosy, Environmental Pharmacology
Central and peripheral neurotransmission, Neurotoxicology, Nerve growth factors, Neural cytoskeletal elements, Brain repair, Cellular and molecular mechanisms of addiction, Developmental and neurodegenerative disorders, Neuro-immune interactions, Neurotoxicology, Nutrient transport in the brain, Synaptic development and plasticity
Pharmaceutical Formulations Market, Licensing, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, E-pharma marketing, Post-market surveillance, Generic Drug Market and Contract Manufacturing Manufacturing and Health Economics
Analytical Techniques, Mass Spectrometry Method Development and Validation, HPLC Method Development and Validation, Spectroscopic Techniques, Mass Spectrometry in Bioanalysis, Advances in Sample Preparation for Bioanalytical Techniques, Qualitative Analytical Techniques, Qualitative Analysis
Nutraceuticals in Disease Prevention and Therapy, Personalized nutrition and medicine, Probiotics and Prebiotics, Nutraceuticals for Weight Management, Dietary Supplements & Functional foods, Nutraceuticals Market- Trends, Skincare Supplements and Cosmetics
Rare diseases, Orphan Drugs Policy, Gene therapy development, Development Trends and Strategies on Orphan Drugs, Challenges in Rare Diseases, Clinical Research and Drug Approvals for Rare Diseases, Cell and Gene therapies, Genetic testing, Gene editing
Product Testing, Microbiological Safety and Cosmetics, SkinCare and HairCare, Packaging, Fragrance, Animal Testing, Plastic microbeads, Endocrine disruptors, Counterfeit products